foxo4-dri patent — ≥99% Purity, COA Included FOX04-DRI (10mg) – Nordsci
FOX04 DRI (10mg) Nordsci FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOX04 DRI Apollo Peptide Sciences Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Buy FOXO4 DRI 10mg Peptide EU Tested Particle Peptides
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




